KDOQI (Kidney Disease Outcomes Quality Initiative)
NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI | Pediatric Bone| Anemia 2006 |
Updates 2006

Clinical Practice Guidelines and Clinical Practice Recommendations
2006 Updates
Hemodialysis Adequacy
Peritoneal Dialysis Adequacy
Vascular Access


I.  CLINICAL PRACTICE GUIDELINES FOR HEMODIALYSIS ADEQUACY

Tables

Table 1 Validated GFR-Estimating Equations
Table 2 Causes of Unusually Low or High Endogenous Creatinine Generation
Table 3 Causes of Unusually Low or High Kidney Tubular Creatinine Secretion
Table 4 Methods for Calculating eKt/V
Table 4A Preferred Measures of the Delivered Dose (in Order of Preference)
Table 5 Recommended Predialysis Blood-Drawing Procedure
Table 6 Slow-Blood-Flow Method for Obtaining the Postdialysis Sample
Table 7 Stop-Dialysate-Flow Method of Obtaining the Postdialysis Sample
Table 8 Effect of HD Dose on Mortality
Table 9 Fraction of Treatments With an spKt/V Greater Than 1.2 When Targeting 1.2 to 1.4 per Dialysis
Table 10 Effect of Residual Kidney Function on Mortality
Table 11 Complications That May Prompt Initiation of Kidney Replacement Therapy

Table 12

Effect of High Flux Dialysis on Mortality, Cardiovascular Mortality and β2 Microglobulin (β2M)
Table 13 Minimum spKt/V Values Corresponding to a stdKt/V of Approximately 2.0 per Week
Table 14 Effect of Dialyzer Reuse on Mortality
Table 15 Efforts to Protect RKF
Table 16 Potential Insults to RKF
Table 17 Effect of Pharmacologic Interventions on Loss of Residual Kidney Function
Table 18 Values for k at Different Dialysis Frequencies and BUN Targets
Table 19 Minimum spKt/V Required to Achieve a stdKt/V of 2.0 per Week

Figures

Figure 1.

Impact of Ultrafiltration on Delivered Dose of HD Measured By Using spKt/V and URR
Figure 2. eKt/V as a Function of Dialysis Treatment Time
Figure 3. Components of Postdialysis Urea (BUN) Rebound
Figure 4. Stop-dialysate Method for Postdialysis Blood Sampling
Figure 5. Illustration of the “Lag Phenomenon”
Figure 6. Effect of Residual Native Kidney Clearance (Kr)